Histopathologic Changes in Two Mouse Models of Asthma


Olmez D., Babayigit A., Erbil G., Karaman O., BAĞRIYANIK H. A., Yilmaz O., ...Daha Fazla

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, cilt.19, sa.2, ss.132-138, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 2
  • Basım Tarihi: 2009
  • Dergi Adı: JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.132-138
  • Anahtar Kelimeler: Mice, Asthma, Remodeling, Nebulized ovalbumin, Intranasal ovalbumin
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: No studies to date have compared mouse models of asthma by evaluating airway histopathology. Objective: To compare 2 such models by studying chronic histopathologic changes of the airways using light and electron microscopy. Methods: Twenty-one male BALB/c mice were divided into 3 groups: a nebulization group sensitized via an intraperitoneal injection of 10 mu g ovalbumin on days 0 and 14 and exposed to 2.5% aerosolized ovalbumin 3 days a week over the subsequent 8 weeks; an intranasal group sensitized via 2 intraperitoneal injections of 100 mu g ovalbumin on days 0 and 14 and administered an intranasal dose of 500 mu g ovalbumin on days 14, 27, 28, 29, 47, 61, 73, 74, and 75; and a control group that received nothing. Airway histopathologies were evaluated. Results: Basement membrane, epithelium, and subepithelial smooth muscle layer thicknesses and mast and goblet cell numbers were significantly higher in the nebulization group than in the control group. With the exception of mast cell numbers, these parameters were also significantly higher in the intranasal group than in the control group. On comparing the intranasal and the nebulization group, goblet cell numbers were significantly higher in the former and mast cells in the latter. Conclusion: Both models replicated all the structural parameters of asthma except for mast cell numbers in the intranasal group (no significant difference with respect to the control group). Our findings do not provide sufficient evidence that one protocol is superior to the other. Larger studies are needed to compare different asthma protocols.